(Q39459741)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448275%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Direct renin inhibitor, aliskiren, attenuates the progression of non-alcoholic steatohepatitis in the rat model (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448275%20AND%20SRC:MED&resulttype=core&format=json

non-alcoholic steatohepatitis

24 February 2020

main subject

steatohepatitis

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448275%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Yosuke Aihara

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448275%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Hitoshi Yoshiji

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448275%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Kosuke Kaji

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448275%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Tadashi Namisaki

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448275%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Yusaku Shirai

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448275%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Akitoshi Douhara

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448275%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Kei Moriya

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448275%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Hideto Kawaratani

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448275%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Hiroshi Fukui

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448275%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

28 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448275%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448275%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448275%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448275%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

1241-1250

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448275%20AND%20SRC:MED&resulttype=core&format=json

Nonalcoholic fatty liver disease

24 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Clinical and pathological progression of non-alcoholic steatohepatitis to hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up st

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Hydrogen-rich water prevents progression of nonalcoholic steatohepatitis and accompanying hepatocarcinogenesis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Adenosine A(2a) receptor stimulation prevents hepatocyte lipotoxicity and non-alcoholic steatohepatitis (NASH) in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Angiogenesis in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Basic and therapeutic aspects of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Tumor angiogenesis: molecular pathways and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Leptin-mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Crosstalk between angiogenesis, cytokeratin-18, and insulin resistance in the progression of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Halting the interaction between vascular endothelial growth factor and its receptors attenuates liver carcinogenesis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

The clinical toxicity profile of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) targeting angiogenesis inhibitors; a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

The role of the renin-angiotensin system in liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Losartan, an angiotensin-II type 1 receptor blocker, attenuates the liver fibrosis development of non-alcoholic steatohepatitis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Restoration of the blood pressure circadian rhythm by direct renin inhibition and blockade of angiotensin II receptors in mRen2.Lewis hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Aliskiren improves left ventricular dysfunction and reduces cardiac dilation in Syrian cardiomyopathic hamsters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Prorenin induces ERK activation in endothelial cells to enhance neovascularization independently of the renin-angiotensin system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

(Pro)renin receptor-mediated activation of mitogen-activated protein kinases in human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Possible involvement of angiogenesis in chronic liver diseases: interaction among renin-angiotensin-aldosterone system, insulin resistance and oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Fibrosis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Endothelial cell marker expression in dysplastic lesions of the liver: an immunohistochemical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Different roles of 8-hydroxyguanine formation and 2-thiobarbituric acid-reacting substance generation in the early phase of liver carcinogenesis induced by a choline-deficient, L-amino acid-defined diet in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Branched-chain amino acids suppress insulin-resistance-based hepatocarcinogenesis in obese diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Selective aldosterone blocker, eplerenone, attenuates hepatocellular carcinoma growth and angiogenesis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Aliskiren attenuates chronic carbon tetrachloride-induced liver injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

Prorenin Induces Intracellular Signaling in Cardiomyocytes Independently of Angiotensin II

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12081

21 January 2018

Identifiers

DOI

10.1111/HEPR.12081

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448275%20AND%20SRC:MED&resulttype=core&format=json

release_d6e3lg4mm5d3hi5twkfwr65kie

24 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/d6e3lg4mm5d3hi5twkfwr65kie

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference